John Golubieski compensation by year
Axsome Therapeutics Summary Compensation Table · all 2 fiscal years held| Component | FY2017 | FY2018 |
|---|---|---|
| Salary | $131,875 | $115,833 |
| Bonus | $50,000 | $-50,000 |
| Stock awards | $0 | $0 |
| Option awards | $519,616 | $0 |
| Non-equity incentive | $48,957 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $0 | $0 |
| Total | $750,448 | $65,833 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Axsome Therapeutics, Inc. DEF 14A filed April 26, 2019, accession 0001558370-19-003404, and prior-year filings.
How this page was built: the Axsome Therapeutics, Inc. filed document, accession 0001558370-19-003404. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2019.
Axsome Therapeutics’s named executive officers, FY2017
as the company reported each| Named executive officer | Role | FY2017 total |
|---|---|---|
| Herriot Tabuteau | Chief Executive Officer and Chairman of the Board | $1,123,352 |
| John Golubieski · this page | Former Chief Financial Officer | $750,448 |
The full Axsome Therapeutics compensation record
free company briefThis page is one person within Axsome Therapeutics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Axsome Therapeutics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Axsome Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.